A roundup of scientific studies on the novel coronavirus and efforts to find treatments and vaccines includes research on Covid-19 patients who still have symptoms 6 months after falling ill.
Blocking TNF production could offer a more effective solution for the treatment of COVID-19.
Using blood plasma from Covid-19 survivors to treat patients with severe pneumonia caused by the novel coronavirus showed little benefit, according to data released from a clinical trial in Argentina.
Researchers at Washington University School of Medicine in St. Louis published the results of a clinical trial evaluating an antidepressant, fluvoxamine, for early treatment for Covid-19.
In a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines, Covid-19 antibodies last at least three months and so do symptoms for many.
U.S. President Donald Trump had no Covid-19 symptoms for the past 24 hours, with a physical examination and his vital signs showing his condition remains sable, White House physician Sean Conley said.
Regeneron Pharmaceuticals Inc.’s experimental two-antibody cocktail reduced viral levels and improved symptoms in non-hospitalized Covid-19 patients.
A study of Fitbit wearers concludes that almost 50 percent of Covid-19 cases can be detected a day before enrollees in the study reported the onset of symptoms, and with 70 percent specificity.
According to a new study by Worldwide Partners, the effect that Covid-19 is having on digital health adoption is set to be transformative. The survey that was conducted shows technology is playing a crucial and growing role in mitigating the healthcare crisis, especially via telehealth.
According to a study published in the journal Science Advances, an international team of researchers led by neuroscientists at Harvard Medical School uncovered which olfactory cell types are most vulnerable to infection by SARS-CoV-2, which causes Covid-19.